DANIELLE KEENAN: Open Payments
NPI 1710350244 · ENCINITAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$642 in 6 payments from 5 companies in 2025. Trend: 2023 $148 · 2024 $514 · 2025 $642
Food & beverage: $642
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $222 |
| Alnylam Pharmaceuticals Inc. | 1 | $146 |
| Novo Nordisk Inc | 1 | $119 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $104 |
| Intra-Sana Laboratories | 1 | $50 |
Products named: REPATHA, AMVUTTRA, Wegovy, Kerendia, RELTONE 200 MG.
Industry payments across CA — which companies pay providers there.
